Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy.
Akihito KawazoeAkihito KawazoeToshihiro SuzukiMasahito KawazuToshihide UenoKazumasa TakenouchiYoshiaki NakamuraYasutoshi KubokiDaisuke KotaniTakashi KojimaHideaki BandoSaori MishimaTakeshi KuwataNaoya SakamotoJun WatanabeHiroyuki ManoMasafumi IkedaKohei ShitaraItraru EndoTetsuya NakatsuraTakayuki YoshinoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Several transcriptomic features, including CMS classification and related genes, were associated with response to PD-1 blockade in MSI-H/dMMR gastrointestinal tumors. These findings can help develop predictive biomarkers or combination immunotherapies.